CCOYX | RIFYX | CCOYX / RIFYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 18 years | - |
Gain YTD | 3.298 | 2.249 | 147% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.6B | 207M | 7,053% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 17.75 | 36.63 | 48% |
Returns for 3 years | 10.34 | 15.42 | 67% |
Returns for 5 years | 63.12 | 14.73 | 428% |
Returns for 10 years | N/A | 70.08 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SLVP | 12.36 | 0.06 | +0.49% |
iShares MSCI Global Silver&Mtls Mnrs ETF | |||
DBEM | 24.90 | 0.12 | +0.49% |
Xtrackers MSCI Em Mkts Hdg Eq ETF | |||
ONEY | 111.88 | 0.39 | +0.35% |
SPDR® Russell 1000® Yield Focus ETF | |||
IQLT | 37.83 | 0.09 | +0.24% |
iShares MSCI Intl Quality Factor ETF | |||
FTXH | 26.92 | -0.20 | -0.74% |
First Trust Nasdaq Pharmaceuticals ETF |